| Potomac Behavioral And Occupational Therapy | |
|
249 Henderson Ave, Cumberland, MD 21502-1638 | |
| (240) 362-7444 | |
| Not Available |
| Full Name | Potomac Behavioral And Occupational Therapy |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 249 Henderson Ave, Cumberland, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063909448 | NPI | - | NPPES |
| 240904600 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Potomac Behavioral And Occupational Therapy 249 Henderson Ave, Cumberland, MD 21502-1638 Ph: (240) 362-7444 | Potomac Behavioral And Occupational Therapy 249 Henderson Ave, Cumberland, MD 21502-1638 Ph: (240) 362-7444 |
News Archive
Patients who died from COVID in 2020 were almost 12 times more likely to die in a medical facility than patients who died from any cause in 2018, reports a new Northwestern Medicine study.
Energy drinks are all the buzz these days, particularly as controversy rises on the impact they have on the human body. As such, the Institute for Good Medicine at the Pennsylvania Medical Society recently launched its first web show titled Good Medicine at www.myfamilywellness.org, featuring this controversial topic.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official change of its name to the Cell and Gene Therapy Catapult.
EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, today announced plans to move forward with a Phase 2a clinical trial in the U.S. using its formulation of EGFR-targeted, EDV nanocells packaged with doxorubicin for the treatment of recurrent glioblastoma (GBM), a common and aggressive type of brain tumor.
A compelling new study conducted by an international team of researchers has demonstrated that the widely used blood-thinning medication - heparin - can block infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
Mrs. Lisa Kay Stewart, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10301 Christie Rd Ne, Cumberland, MD 21502 Phone: 301-724-1400 | |
Mr. Denis Michael Oleary, OTRIL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 Buckingham Road, Cumberland, MD 21502 Phone: 301-724-5560 | |
Cortney N Riden, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 309 Willowbrook Rd, Suite 2, Cumberland, MD 21502 Phone: 301-777-2170 Fax: 301-777-2173 | |
Ms. Suzanne Marie Kalinoski, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 157 Baltimore St, Cumberland, MD 21502 Phone: 301-722-1450 | |
Mrs. Chelsea Shye Freas Boyle, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 157 Baltimore St, Cumberland, MD 21502 Phone: 301-722-3215 Fax: 301-722-1450 | |
Veronica Maria Walsh Mingolelli, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15701 Bottle Run Rd Ne, Cumberland, MD 21502 Phone: 301-338-2190 |